Testing effectiveness (Phase 2)Study completedNCT01651104
What this trial is testing
Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects
Who this might be right for
Human Influenza
Novartis Vaccines 63
Showing 20 of 0 results